Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short-term Investments Total Current Liabilities Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

CorMedix (CRMD) Convertible Debt (2018 - 2019)

CorMedix (CRMD) has disclosed Convertible Debt for 4 consecutive years, with $6.7 million as the latest value for Q2 2019.

Quarterly Convertible Debt changed N/A to $6.7 million in Q2 2019 from the year-ago period, while the trailing twelve-month figure was $6.7 million through Jun 2019, changed N/A year-over-year, with the annual reading at $6.1 million for FY2018, N/A changed from the prior year.
Convertible Debt hit $6.7 million in Q2 2019 for CorMedix, up from $6.4 million in the prior quarter.
In the past five years, Convertible Debt ranged from a high of $6.7 million in Q2 2019 to a low of $6.1 million in Q4 2018.